Free tool
FAERS Monitor: Caldolor
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022348 or its brand name (Caldolor, Ibuprofen). Reports on generic versions are filed under their own applications.
Reports
201,240
Serious
146,657
73% of reports
Hospitalization
71,568
Death reported
16,456
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective15,930
- pain15,218
- fatigue14,694
- nausea13,725
- headache12,243
- arthralgia11,062
- dyspnoea10,659
- vomiting10,121
- diarrhoea9,835
- rash9,144
- off label use8,772
- dizziness8,294
- pruritus8,025
- pyrexia7,972
- acute kidney injury6,763
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,609 |
| 2005 | 2,142 |
| 2006 | 2,049 |
| 2007 | 2,109 |
| 2008 | 1,779 |
| 2009 | 2,763 |
| 2010 | 3,973 |
| 2011 | 5,696 |
| 2012 | 7,072 |
| 2013 | 6,754 |
| 2014 | 6,567 |
| 2015 | 9,101 |
| 2016 | 12,510 |
| 2017 | 11,350 |
| 2018 | 15,600 |
| 2019 | 16,689 |
| 2020 | 15,485 |
| 2021 | 15,252 |
| 2022 | 14,645 |
| 2023 | 13,671 |
| 2024 | 12,643 |
| 2025 | 12,813 |
| 2026 | 8,959 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,852,919 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acute kidney injurySignal | 6,763 | 4.8 | 4.7 | 19,499 |
| arthralgiaSignal | 11,062 | 2.8 | 2.8 | 12,991 |
| painSignal | 15,218 | 2.6 | 2.6 | 15,438 |
| pyrexiaSignal | 7,972 | 2.4 | 2.4 | 6,736 |
| vomitingSignal | 10,121 | 2.3 | 2.2 | 7,256 |
| rashSignal | 9,144 | 2.2 | 2.2 | 6,113 |
| pruritusSignal | 8,025 | 2.2 | 2.2 | 5,287 |
| headacheSignal | 12,243 | 2.1 | 2.0 | 6,763 |
| fatigue | 14,694 | 2.0 | 2.0 | 7,387 |
| dyspnoea | 10,659 | 2.0 | 1.9 | 5,264 |
| nausea | 13,725 | 1.8 | 1.8 | 5,243 |
| dizziness | 8,294 | 1.8 | 1.7 | 2,687 |
| diarrhoea | 9,835 | 1.6 | 1.6 | 2,257 |
| drug ineffective | 15,930 | 1.3 | 1.2 | 941 |
| off label use | 8,772 | 1.0 | 1.0 | 19 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.